139 related articles for article (PubMed ID: 2249199)
1. Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder.
Schapers RF; Pauwels RP; Havenith MG; Smeets AW; van den Brandt PA; Bosman FT
Cancer; 1990 Dec; 66(12):2583-8. PubMed ID: 2249199
[TBL] [Abstract][Full Text] [Related]
2. Value of immunohistochemical laminin staining in transitional cell carcinoma of human bladder.
Abou Farha KM; Janknegt RA; Kester AD; Arends JW
Urol Int; 1993; 50(3):133-40. PubMed ID: 7682019
[TBL] [Abstract][Full Text] [Related]
3. p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.
Soini Y; Turpeenniemi-Hujanen T; Kamel D; Autio-Harmainen H; Risteli J; Risteli L; Nuorva K; Pääkkö P; Vähäkangas K
Br J Cancer; 1993 Nov; 68(5):1029-35. PubMed ID: 8217593
[TBL] [Abstract][Full Text] [Related]
4. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
5. Distribution of basement membrane antigens in bladder carcinomas: an additional prognostic parameter. Immunohistochemical study.
Alampi G; Gelli C; Mestichelli M; Brizio R; Piccaluga A
Arch Anat Cytol Pathol; 1989; 37(5-6):224-30. PubMed ID: 2604440
[TBL] [Abstract][Full Text] [Related]
6. Basement membranes in urothelial carcinoma.
Conn IG; Crocker J; Wallace DM; Hughes MA; Hilton CJ
Br J Urol; 1987 Dec; 60(6):536-42. PubMed ID: 3427340
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
8. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
9. Relation between basement membrane degradation and serum levels of laminin P1 in patients with transitional cell carcinoma of the bladder.
Abou Farha KM; Menheere PP; Nieman FH; Janknegt RA; Arends JW
Urol Int; 1993; 50(1):13-6. PubMed ID: 8434420
[TBL] [Abstract][Full Text] [Related]
10. DNA ploidy of bladder cancer using bladder biopsy supernate specimens.
Loughman NT; Lin BP; Dent OF; Newland RC
Anal Quant Cytol Histol; 2003 Jun; 25(3):146-58. PubMed ID: 12882086
[TBL] [Abstract][Full Text] [Related]
11. The prognosis of oral mucosal squamous cell carcinomas: a comparison of clinical and histopathological grading and of laminin and type IV collagen staining.
Firth NA; Reade PC
Aust Dent J; 1996 Apr; 41(2):83-6. PubMed ID: 8670039
[TBL] [Abstract][Full Text] [Related]
12. Collagen IV staining pattern in bladder carcinomas: relationship to prognosis.
Daher N; Abourachid H; Bove N; Petit J; Burtin P
Br J Cancer; 1987 Jun; 55(6):665-71. PubMed ID: 3304387
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer.
Lipponen PK
J Cancer Res Clin Oncol; 1993; 119(5):295-300. PubMed ID: 7680044
[TBL] [Abstract][Full Text] [Related]
15. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
[TBL] [Abstract][Full Text] [Related]
16. Basement membrane and extracellular interstitial matrix components in bladder neoplasia--evidence of angiogenesis.
Deen S; Ball RY
Histopathology; 1994 Nov; 25(5):475-81. PubMed ID: 7532615
[TBL] [Abstract][Full Text] [Related]
17. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx.
Nerlich AG; Lebeau A; Hagedorn HG; Sauer U; Schleicher ED
Anticancer Res; 1998; 18(5A):3515-20. PubMed ID: 9858933
[TBL] [Abstract][Full Text] [Related]
18. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.
Sarkis AS; Dalbagni G; Cordon-Cardo C; Zhang ZF; Sheinfeld J; Fair WR; Herr HW; Reuter VE
J Natl Cancer Inst; 1993 Jan; 85(1):53-9. PubMed ID: 7677935
[TBL] [Abstract][Full Text] [Related]
19. Immunohistologic distribution of basement membrane in oral squamous cell carcinoma.
Kumagai S; Kojima S; Imai K; Nakagawa K; Yamamoto E; Kawahara E; Nakanishi I
Head Neck; 1994; 16(1):51-7. PubMed ID: 8125788
[TBL] [Abstract][Full Text] [Related]
20. Prognostic aspects of the loss of epithelial basement membrane components in preinvasive and invasive laryngeal carcinomas.
Hagedorn HG; Tübel J; Wiest I; Schleicher ED; Nerlich AG
Anticancer Res; 1998; 18(1A):201-7. PubMed ID: 9568078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
